clinical trial · NCT01068041
Effects of PH3 in Diabetic Nephropathy
Diabetic NephropathyPH3
brief summary
The primary objective of this clinical study is to evaluate the effectiveness and safety of PH3 for patients with diabetic nephropathy. The secondary objectives are to identify the optimal dosage for subsequent studies and to provide basis for the next confirmatory study in study design, endpoints, and study methodologies.
started
Aug 1, 2010
primary completion
Jul 1, 2014
completion
Sep 1, 2015
last updated
Jun 5, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol